by Jennifer Kite-Powell – Forbes –
Regenerative medicine is a segment of medicine that focuses on treatments to repair or replace damaged tissues, organs or cells and restore function from disease, ageing, trauma or congenital abnormalities.
The market is estimated to be valued at $16 billion in 2023, and sources predict it will reach $49 billion in four years by 2028. Analysts report the market is primarily driven by personalized medicine, expanded therapeutic areas, and more regulatory approvals.
3D bioprinting3D bioprinting offers researchers the potential to study disease progression and screen new treatments for conditions from end-stage organ failure to cartilage defects.
